Tech Company Financing Transactions

NuSirt Biopharma Funding Round

NuSirt Biopharma, based in Nashville, secured $3 million from private investors.

Transaction Overview

Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3835 Cleghorn Ave. 200
Nashville, TN 37215
USA
Email Address
Overview
NuSirt Biopharma, Inc. has developed a breakthrough technology platform with the goal of enabling the use of natural compounds to create synergy with known pharmaceuticals to prevent and treat chronic diseases resulting from over-nutrition and aging.
Profile
NuSirt Biopharma LinkedIn Company Profile
Social Media
NuSirt Biopharma Company Twitter Account
Company News
NuSirt Biopharma News
Facebook
NuSirt Biopharma on Facebook
YouTube
NuSirt Biopharma on YouTube

Management Team

Title
Name
Email & Social
Chief Operating Officer
Barbara Cannon
  Barbara Cannon LinkedIn Profile  Barbara Cannon Twitter Account  Barbara Cannon News  Barbara Cannon on Facebook
Chief Scientific Officer
Michael Zemel
  Michael Zemel LinkedIn Profile  Michael Zemel Twitter Account  Michael Zemel News  Michael Zemel on Facebook
President
Joseph Cook
  Joseph Cook LinkedIn Profile  Joseph Cook Twitter Account  Joseph Cook News  Joseph Cook on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2014: Royalty Exchange venture capital transaction
Next: 12/31/2014: Cebix venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary